Open mobile menu
Model.SiteSettings!.GetInTouchLink!.Name Contact Us
Jroberts Jruaux Dpingstone 03 B012378 CROPPED
Insights

News

Stay up to date with news about Secerna and intellectual property topics.

VENCLEXTA®

A to Z: Drugs in Highlight: V is for VENCLEXTA®

News A to Z Feature 30/04/2025

Our A to Z series highlights VENCLEXTA® (venetoclax) from AbbVie, a medication used to treat both chronic lymphocytic leukaemia (CLL) and acute myeloid leukaemia (AML). This article explores its mechanism of action, clinical applications, and the patent protection surrounding this important drug.

Read more
Secerna Office
News 29/01/2024

Join Secerna's Chemistry & Pharma Team as a Finalist/Newly Qualified Patent Attorney

Plant Baserd Meat
News 23/01/2024

Sustainability Through Innovation: IP Strategies for Meat Alternatives

Secerna Website Images 2023 (35)
Industry news, News 19/01/2024

Apple Watch Series 9 & Ultra 2 Grounded in US: Blood Oxygen Patent Dispute Takes Flight

Georgia EPO
European, Industry news, News 15/01/2024

New Route to Patent Protection in Georgia: European Applications Now Validated

Secerna Website Images 2023 (33)
Industry news, News 11/01/2024

Why AI-Generated Patent Applications Can Put Your Innovation at Risk

Protect Patent Portfolio
Industry news, News 02/01/2024

Patent Portfolio Management: The Key to Protecting Innovation

NYE 2023 24
News 29/12/2023

How Intellectual Property Shapes New Year's Eve Shenanigans

Secerna Website Images 2023 (26)
Industry news, News 20/12/2023

UK Supreme Court Declares AI Can't Claim Patent Inventorship

Enlarged Board Of Appeal To Address Description Amendment Rules
European, Industry news, News 19/12/2023

Enlarged Board of Appeal to Address Description Amendment Rules

10 11 12 13 14 15 16 17 18 19 20